Novavax (NVAX)
(Delayed Data from NSDQ)
$18.17 USD
-1.39 (-7.08%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $18.17 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Novavax, Inc. [NVAX]
Reports for Purchase
Showing records 81 - 100 ( 296 total )
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 9122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 82122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 81122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine; Reiterate Buy and $207 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
VRBPAC Vote Overwhelmingly Positive; Moves NVX-CoV2373 Closer to U.S. Authorization
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
COVID-Influenza Combination Vaccine Shows Promising Results; Reiterate Buy and $207 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department